Authors: Squara, P Dhainaut, JFA Artigas, A Carlet, J

Citation: P. Squara et al., Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS study (vol 24, pg 1018, 1998), INTEN CAR M, 25(2), 1999, pp. 247-247

Authors: Dhainaut, JFA Vinsonneau, C Journois, D

Citation: Jfa. Dhainaut et al., Hemofiltration and left ventricular function in sepsis: Mechanisms and clinical implications, CRIT CARE M, 27(3), 1999, pp. 473-474

Authors: Chiche, JD Dhainaut, JFA

Citation: Jd. Chiche et Jfa. Dhainaut, Inhaled nitric oxide for right ventricular dysfunction in chronic obstructive pulmonary disease patients: Fall or rise of an idea?, CRIT CARE M, 27(10), 1999, pp. 2299-2301

Authors: Dhainaut, JFA Tenaillon, A Hemmer, M Damas, P Le Tulzo, Y Radermacher, P Schaller, MD Sollet, JP Wolff, M Holzapfel, L Zeni, F Vedrinne, JM de Vathaire, F Gourlay, ML Guinot, P Mira, JP Holzapfel, L Demingeon, G Piralla, B Zeni, F Bertrand, JC Motin, J Vedrinne, JM Dreyfuss, D Coste, F Mier, L Faller, JP Ruyer, O Feissel, M Engquist, A Strom, J Bonde, J Desmonts, JM Montravers, P Lagoueyte, JF Tenaillon, A Lawkoune, JM Boiteau, R Cardinaud, JP Benissan, G Chastre, J Gibert, C Daoudal, P Delacourt, M Fouet, P Hilpert, F Smithies, M Bihari, D Perrotin, D Dequin, PF Tempelhof, G Carton, MJ Payen, D Mateo, J Carlet, J Lescale, O Bleichner, G Sollet, JP Fagon, JY Novara, A Dhainaut, JF Marin, N Galiacy, JL Morteau, B Wolff, M Vachon, F Durocher, A Saulnier, F Herman, B Wysocki, M Duswald, M Radermacher, P Georgieff, M Colardyn, F Robert, D Park, G Mattei, M Charbonneau, P Chopin, C Breulmann, M Holzheimer, M Damas, F Ozier, Y Fraisse, F Gastrinne, H Blanc, PL Domart, Y Aube, H Descamps, JM Nitenberg, G Tempe, JD Bonnet, F Jaeger, A Villers, D Barale, F Falke, K Ulbricht, M Samii, K Pepperman, M Tonnesen, E Gattinoni, L Braschi, A Arich, C Lienhart, A Offenstadt, G Eurin, B Schlemmer, B Goenen, M Bahr, R Brienza, A Antonelli, M Damas, P Edwards, D

Citation: Jfa. Dhainaut et al., Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial, CRIT CARE M, 26(12), 1998, pp. 1963-1971